IDH-wild-type glioblastomas followed a similar trend; the vast majority of cases had high overall copy number variation, but the few cases with < 10% total copy number variation had a significantly better clinical outcome in terms of both progression-free and overall survival [172, 175, 212]. This evidence concerns the gene IDH1 and glioblastoma.